Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Galen, Louise Sandraen_US
dc.contributor.authorXu, Xiaomengen_US
dc.contributor.authorKoh, Mark Jean Aanen_US
dc.contributor.authorThng, Stevenen_US
dc.contributor.authorCar, Josipen_US
dc.identifier.citationvan Galen, L. S., Xu, X., Koh, M. J. A., Thng, S. & Car, J. (2019). Eczema apps conformance with clinical guidelines : a systematic assessment of functions, tools and content. British Journal of Dermatology, 182(2), 444-453.
dc.description.abstractBackground: Eczema is a prevalent complex skin condition requiring active disease monitoring and personalized education. No studies have assessed the quality of apps that aim to support eczema self-management.Objectives: To evaluate the quality and comprehensiveness of English, Chinese and Spanish self-management eczema smartphone apps for patients and/or their caregivers. Methods: A systematic assessment of eczema apps from July 2018 to November 2018. The assessment criteria were based on conformance with international eczema guidelines. The following domains were assessed: consistency and comprehensiveness of eczema-specific educational information; quality and comprehensiveness of eczema-specific tracking functions; compliance with health information best practice principles. Results: In total, 98 apps were assessed: 82 (84%) provided educational information; 38 (39%) tracking functions; and 13 (13%) both. We found that 34% (28/82) of apps provided misleading information, particularly regarding aspects of treatment and disease progression of eczema. Only 15% (12/82) provided international guideline supported information on pharmacological therapies and 16% (13/82) on nonpharmacological therapies. Among 38 apps with a tracking function, 82% (31/38) measured specific symptoms, disease severity or current skin condition and 89% (34/38) helped users to record medication usage including application of topicals. Environmental or dietary allergens were recorded by 34% (13/38). None of the included apps complied with all criteria for educational information, tracking functions or health information principles. Conclusions: Eczema apps have not yet reached their potential. The large variance in quality of eczema apps highlights the need for quality assurance mechanisms for health apps and guidance for clinicians that would enable them to make personalized recommendations for patients and caregivers.en_US
dc.description.sponsorshipAgency for Science, Technology and Research (A*STAR)en_US
dc.description.sponsorshipNanyang Technological Universityen_US
dc.relation.ispartofBritish Journal of Dermatologyen_US
dc.rights© 2019 British Association of Dermatologists. All rights reserved.en_US
dc.titleEczema apps conformance with clinical guidelines : a systematic assessment of functions, tools and contenten_US
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en_US
dc.contributor.researchCentre for Population Health Sciencesen_US
dc.subject.keywordsAtopic Dermatitisen_US
dc.subject.keywordsSmartphone Appsen_US
dc.description.acknowledgementThis research was supported through the NTU Research Scholarship by Nanyang Technological University and the Skin Research Grant by the Skin Research Institute of Singapore (SRIS), a tripartite partnership between the Agency for Science, Technology and Research (A*STAR), National Healthcare Group through its National Skin Centre (NHG) and the Nanyang Technological University (NTU).en_US
item.fulltextNo Fulltext-
Appears in Collections:LKCMedicine Journal Articles

Page view(s)

Updated on Sep 26, 2021

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.